Non-Hodgkin lymphoma Posts on Medivizor
Navigation Menu

Non-Hodgkin lymphoma Posts on Medivizor

Impact of multi-drug resistant organisms after stem cell transplantation

Posted by on Dec 16, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the impact of multi-drug resistant organisms in patients who had undergone stem cell treatment. The study concluded that patients colonized with multi-drug resistant organisms should be watched closely for infections after transplantation.  Some background Stem cell transplantation is a treatment used in...

Read More

CAR-T cell therapy and infection risk

Posted by on Dec 16, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined infection risk in leukemia and lymphoma patients treated with CAR-T cell therapy, a new type of immunotherapy. Researchers reported that infection rates were comparable to other salvage therapies.  Some background Chimeric antigen receptor (CAR) T-cell therapy helps the immune system to fight cancer cells. In...

Read More

CAR-T cell therapy and infection risk

Posted by on Dec 16, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined infection risk in leukemia and lymphoma patients treated with CAR-T cell therapy, a new type of immunotherapy. Researchers reported that infection rates were comparable to other salvage therapies.  Some background Chimeric antigen receptor (CAR) T-cell therapy helps the immune system to fight cancer cells. In...

Read More

NHL with central nervous system involvement: Autologous stem cell transplant after high-dose chemotherapy an effective treatment option

Posted by on Dec 12, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined outcomes of autologous stem cell transplants after high-dose chemotherapy in non-Hodgkin lymphoma (NHL) patients with central nervous system (CNS) involvement. This study reported durable remission and good disease control for NHL with CNS involvement.  Some background Many forms of NHL are treatable. When...

Read More

PTSD and Cancer

PTSD and Cancer

Posted by on Dec 11, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 0 comments

“I think all too often we underestimate the impact of a cancer diagnosis on the mental health and well-being of the individual, thus it goes unaddressed.” ~Stephanie Zimmerman, MSN Receiving a diagnosis of cancer can bring on feelings of worry, fear, dread, anger, uncertainty and loss.  Research indicates that, for some people, these symptoms of...

Read More

Effectiveness of bortezomib, cladribine, and rituximab in mantle cell and follicular lymphomas

Posted by on Dec 9, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the combination of bortezomib (Velcade), cladribine (Leustatin), and rituximab (Rituxan) for patients with mantle cell or follicular lymphoma. The authors concluded that this combination was effective and can be an alternative for patients who cannot undergo stem cell transplantation. Some background There is no...

Read More

Current treatment options for patients with relapsed or difficult to treat mantle cell lymphoma

Posted by on Dec 4, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This review explores the current treatments for patients with relapsed or difficult to treat mantle cell lymphoma.  Some background Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma. Patients with relapsed MCL generally have poor outcomes. These patients with relapsed or difficult to treat (refractory) MCL have...

Read More

The effectiveness of radiotherapy following autologous stem cell transplantation in patients with diffuse large B-cell lymphoma

Posted by on Dec 4, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effect of radiotherapy after autologous stem cell transplantation for patients with relapsed or difficult to treat diffuse large B-cell lymphoma. The study concluded that patients had better tumor control when treated with involved-field radiotherapy after autologous stem cell transplantation.  Some...

Read More

Lenalidomide in mantle cell lymphoma patients already treated with ibrutinib

Posted by on Nov 30, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the effectiveness of lenalidomide (Revlimid) in patients with mantle cell lymphoma (MCL) already treated with ibrutinib (Imbruvica). The authors concluded that lenalidomide was effective following ibrutinib. Some background There is no standard-of-care treatment for patients with relapsed or refractory (did not...

Read More

Use of bortezomib plus rituximab to treat patients with relapsed follicular lymphoma

Posted by on Nov 18, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effectiveness of bortezomib plus rituximab for treating patients with relapsed follicular lymphoma. The study concluded that bortezomib plus rituximab is a safe and effective treatment for patients with relapsed follicular lymphoma.  Some background Follicular lymphoma (FL) is a common type of...

Read More

Upfront autologous stem cell transplantation treatment for patients with high-risk diffuse large B-cell lymphoma

Posted by on Nov 18, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the effectiveness of autologous stem cell transplantation after their first remission for patients with high-risk diffuse large B-cell lymphoma. The study concluded that patients who received autologous stem cell transplantation had better outcomes than those who did not. Some background Diffuse large B-cell...

Read More